3. Hepatitis B Virus
– Hepadnaviridae family
– DNA virus
– Double-shelled particles
– Outer lipoprotein envelope
(surface Ag)
– Inner viral nucleocapsid (core)
– seven genotypes
– four major subtypes.
– All HBV subtypes share one
common antigenic determinant -
"a.“
4. • 42 nm virion, 27nm nucleocapsid core
• Small circular
• 3 particulate forms-spherical, tubular, double
spherical
• HBV DNA codes for 4 sets of viral products
5. Genomic Structure of HBV
Genes Regions Gene products
S S Major protein (S)
S+Pre S2 Middle protein (M)
S+Pre S1 Large protein (L) HBsAg
& S2
C C HBcAg
C+Pre C HbeAg
P DNA polymerase
X HBxAg which contribute in
carcinogenesis by binding
to p53.
6.
7.
8. Antigen Detection- HBsAg,HBcAg,HBeAg
Antibody Detection-Anti HBc, Anti-HBe, Anti-HBs
DNA Detection- HBV DNA
9. Acute Hepatitis B Virus Infection with Recovery
Typical Serologic Course
Titer
HBsAg
0 4 8 12 16 20 24 28 32 36 52 100
Weeks after Exposure
10. Acute Hepatitis B Virus Infection with Recovery
Typical Serologic Course
Titer
HBV DNA
HBsAg
0 4 8 12 16 20 24 28 32 36 52 100
Weeks after Exposure
11. Acute Hepatitis B Virus Infection with Recovery
Typical Serologic Course
HBeAg
Titer
HBV DNA
HBsAg
0 4 8 12 16 20 24 28 32 36 52 100
Weeks after Exposure
12. Acute Hepatitis B Virus Infection with Recovery
Typical Serologic Course
Symptoms
HBeAg
Total anti-HBc
Titer
IgM anti-HBc
HBV DNA
HBsAg
Window
Period
0 4 8 12 16 20 24 28 32 36 52 100
Weeks after Exposure
13. Acute Hepatitis B Virus Infection with Recovery
Typical Serologic Course
Symptoms
HBeAg anti-HBe
Total anti-HBc
Titer
IgM anti-HBc
HBV DNA
HBsAg
0 4 8 12 16 20 24 28 32 36 52 100
Weeks after Exposure
14. Acute Hepatitis B Virus Infection with Recovery
Typical Serologic Course
Symptoms
HBeAg anti-HBe
Total anti-HBc
Titer
IgM anti-HBc
HBV DNA
HBsAg anti-HBs
Window
Period
0 4 8 12 16 20 24 28 32 36 52 100
Weeks after Exposure
15. Treatment and Prevention
Interferon therapy - For HBeAg +ve carriers with
chronic active hepatitis. Response rate is 30 to
40%.
Drugs-
Lamivudine, Adefovir, Entecavir
Vaccination-
Recombinant vaccines
genetically engineered by cloning the S gene of
HBV in Baker’s yeast
16. Hepatitis B Immunoglobulin –
Efficacious within 48 hours of the incident.
It may also be given to neonates whose mothers are
HBsAg and HBeAg positive.
Other measures –
Screening of blood donors, blood and body fluid
precautions.
17. Persons born in hyperendemic areas
Homosexuals
Injection drug users
Patients on dialysis
HIV infected patients
Pregnant women
Family and household contacts and sexual contacts
of HBV-infected persons.